ATC CODE
- J01XC01
INDICATION
Treatment of staphylococcal infections, mainly involving bone and joints:
- Methicillin-sensitive organisms, as alternative to cloxacillin or flucloxacillin.
- Methicillin-sensitive organisms, in combination with cloxacillin or flucloxacillin.
- Methicillin-resistant organisms, as an alternative to e.g. glycopeptides or oxazolidinones (linezolid), especially in cases where prolonged treatment is required.
NEMLC RECOMMENDATION
- Not Approved
REVIEW INDICATORS
- New evidence of clinical comparative efficacy against alternatives, especially regarding long term treatment of. MRSA where the oral preparation may be of benefit in comparison to parenteral glycopeptides and infections with glycopeptide resistant organisms where the potential toxicity of oxazolidinones (linezolid) when used for prolonged periods of time, may be problematic.
DATE RATIFIED
- 13 March 2008